TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Galena Pharma Oy
Closing information (x1000 DKK)
| Closing information | 2016/12 | 2015/12 | 2014/12 |
| Turnover |
27,812
|
23,683 | |
| Financial expenses |
7
|
75
|
82 |
| Earnings before taxes |
2,639
|
157
|
1,630 |
| Total assets |
15,315
|
11,962
|
10,349 |
| Current assets |
1,360
|
1,515
|
6,537 |
| Current liabilities |
7,762
|
8,462
|
4,795 |
| Equity capital |
4,951
|
2,746
|
4,072 |
| - share capital |
2,424
|
2,433
|
2,427 |
| Employees (average) |
25
|
20
|
19 |
Financial ratios
| Fiscal year | 2016/12 | 2015/12 | 2014/12 |
| Solvency |
32.3%
|
23.0%
|
39.3% |
| Turnover per employee |
1,391
|
1,246 | |
| Profit as a percentage of turnover |
0.6%
|
6.9% | |
| Return on assets (ROA) |
17.3%
|
1.9%
|
16.5% |
| Current ratio |
17.5%
|
17.9%
|
136.3% |
| Return on equity (ROE) |
53.3%
|
5.7%
|
40.0% |
| Change turnover |
4,074
|
3,082 | |
| Change turnover % |
17%
|
15% | |
| Chg. No. of employees |
5
|
1
|
0 |
| Chg. No. of employees % |
25%
|
5%
|
0% |
Total value of public sale
| Fiscal year | 2016/12 | 2015/12 | 2014/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.